GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » PanGenomic Health Inc (HAM:LL3) » Definitions » Notes Receivable

PanGenomic Health (HAM:LL3) Notes Receivable : €0.00 Mil (As of Sep. 2024)


View and export this data going back to 2024. Start your Free Trial

What is PanGenomic Health Notes Receivable?

PanGenomic Health's Notes Receivable for the quarter that ended in Sep. 2024 was €0.00 Mil.


PanGenomic Health Notes Receivable Historical Data

The historical data trend for PanGenomic Health's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PanGenomic Health Notes Receivable Chart

PanGenomic Health Annual Data
Trend Dec21 Dec22 Dec23
Notes Receivable
- - -

PanGenomic Health Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Notes Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

PanGenomic Health Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.


PanGenomic Health Notes Receivable Related Terms

Thank you for viewing the detailed overview of PanGenomic Health's Notes Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


PanGenomic Health Business Description

Traded in Other Exchanges
Address
3800 Wesbrook Mall, Suite 102, Vancouver, BC, CAN, V6S 2L9
PanGenomic Health Inc is a precision health company that has developed a self-care digital platform to deliver personalized, evidence-based information about natural treatments to support mental health. The company's mobile app, the Nara App, provides consumers with a knowledge base tailored to an individual's user profile, developed by tracking a user's treatment regimen and their specific genomic, proteomics, and microbiome data. The Company's mission is to promote and improve the health and wellness of people and society by providing a technology platform that identifies plant-based solutions tailored to the health profile of each individual.

PanGenomic Health Headlines

No Headlines